LIFE - Ethos Technologies Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Ethos Technologies Inc.
aTyr Pharma Inc is a biotherapeutics company, engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology.
IPO Date: January 29, 2026
Sector: Financial Services
Industry: Insurance Brokers
Market Cap: $2.3B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.84 | 4.20%
Avg Daily Range (30 D): $1.18 | 3.34%
Avg Daily Range (90 D): $1.01 | 4.16%
Institutional Daily Volume
Avg Daily Volume: .73M
Avg Daily Volume (30 D): 1.41M
Avg Daily Volume (90 D): .89M
Trade Size
Avg Trade Size (Sh.): 83
Avg Trade Size (Sh.) (30 D): 84
Avg Trade Size (Sh.) (90 D): 81
Institutional Trades
Total Institutional Trades: 197
Avg Institutional Trade: $1.85M
Avg Institutional Trade (30 D): $2.14M
Avg Institutional Trade (90 D): $1.86M
Avg Institutional Trade Volume: .07M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $2.33M
Avg Closing Trade (30 D): $3.77M
Avg Closing Trade (90 D): $2.68M
Avg Closing Volume: 93.24K
 
News
Sep 4, 2026 @ 6:51 PM
Ethos Chief Underwriter Nichole Myers Shares Why S...
Source: Not Specified
Jun 3, 2024 @ 12:00 PM
aTyr Pharma Announces Nasdaq Stock Ticker Symbol C...
Source: aTyr Pharma, Inc.
May 24, 2024 @ 8:00 PM
aTyr Pharma Announces Inducement Grants Under Nasd...
Source: aTyr Pharma, Inc.
May 19, 2024 @ 10:35 AM
Wall Street Breakfast: The Week Ahead
Source: Wall Street Breakfast
May 15, 2024 @ 11:00 AM
aTyr Pharma to Present Poster Describing Efzofitim...
Source: aTyr Pharma, Inc.
Financials
  TTM Q2 2026 TTM
Basic EPS $.31 $-.62
Diluted EPS $.3 $-.62
Revenue $189.56M $.19M
Gross Profit $185.54M
Net Income / Loss $19.53M $-60.81M
Operating Income / Loss $18.12M $-63.86M
Cost of Revenue $4.03M
Net Cash Flow $4.25M $-2.44M
PE Ratio    
Splits
Jul 01, 2019 1:14